Author

G. Raimondi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:mouse· 5 Research Focus:host-pathogen & immune response· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:development & morphogenesis· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1

Frequent Co-Authors

M. Iglesias· 3 shared G. Brandacher· 2 shared Y. Zhang· 2 shared A. Arun· 1 shared A. G. Dykema· 1 shared A. R. Cross· 1 shared A. S. Meyer· 1 shared A. Young· 1 shared

Activity by Year

2018-2022 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M. Iglesias

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Integration of exogenous and endogenous co-stimulatory signals by CAR-Tregs

I. Rosado-Sanchez, M. Haque, K. Salim, M. Speck, V. Fung, D. Boardman, M. Mojibian, G. Raimondi, M. K. Levings

This study compares CAR-Treg function with different co-stimulatory domains, finding in vivo equivalence between CARs with and without CD28 despite in vitro differences.

bioRxiv · Nov 10, 2022 · PreprintImmunology

Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection

D. VanDyke, M. Iglesias, J. Tomala, A. Young, J. Smith, J. A. Perry, E. Gebara, A. R. Cross, L. S. Cheung, A. G. Dykema, B. T. Orcutt-Jahns, T. Henclova, J. Golias, J. Balolong, L. M. Tomasovic, , J. B. Spangler

The paper engineers a cytokine/antibody fusion protein that selectively expands regulatory T cells and protects against autoimmune diseases in mouse models.

bioRxiv · May 29, 2022Bioengineering

Automated classification of estrous stage in rodents using deep learning

N. Wolcott, K. Sit, G. Raimondi, T. Hodges, R. Shansky, L. Galea, L. Ostroff, M. Goard

This paper develops a deep learning model to classify estrous stages in rodents with expert-level accuracy, improving efficiency and consistency in rodent research.

bioRxiv · Mar 9, 2022Cell Biology

Design and Characterization of Lipid Nanocarriers for Oral Delivery of Immunotherapeutic Peptides

X. Calderon Colon, Y. Zhang, O. Tiburzi, J. Wang, G. Raimondi, J. Patrone

This paper designs and characterizes lipid nanocarriers for oral delivery of immunotherapeutic peptides, showing they are non-toxic, taken up by immune cells, and accumulate in lymph nodes.

bioRxiv · Jan 27, 2022Immunology

A short course of Tofacitinib sustains the immunoregulatory effect of CTLA4-Ig in presence of inflammatory cytokines and promotes long-term survival of murine cardiac allografts

M. Iglesias, S. Khalifian, B. C. Oh, Y. Zhang, D. Miller, S. Beck, G. Brandacher, G. Raimondi

This study shows that combining Tofacitinib with CTLA4-Ig improves cardiac allograft survival by reducing effector T cells and increasing regulatory T cells in mice.

bioRxiv · Nov 18, 2020Immunology

Type-I interferons inhibit interleukin-10 signaling and favor type 1 diabetes development in NOD mice

M. Iglesias, A. Arun, M. Chicco, B. Lam, C. Talbot, V. Ivanova, W. P. A. Lee, G. Brandacher, G. Raimondi

This study shows that type-I interferons inhibit IL-10 signaling in T cells, promoting type 1 diabetes in NOD mice by altering T cell responses and spatial localization.

bioRxiv · Feb 1, 2018Immunology